Kristin Patrick has served as a director of Niagen Bioscience since April 2022 and currently chairs the Nominating and Corporate Governance Committee while also serving as a member of the Audit Committee since June 2022.
Ms. Patrick currently serves as the President & Chief Marketing Officer of Marc Jacobs, where she leads brand strategy and transformation initiatives. Her appointment brings valuable consumer marketing expertise to the board as Niagen Bioscience continues to expand its consumer-facing business.
With more than 20 years of experience spanning multiple industries including fashion, omnichannel retail, entertainment, consumer packaged goods, and beauty, Ms. Patrick has developed a distinguished reputation as a disruptive, trend-setting brand steward, general manager, and strategist. Her extensive experience covers diverse channels including food, drug, convenience, mass market, luxury, mid-tier, and direct-to-consumer.
Throughout her career, Ms. Patrick has held leadership positions at renowned global brands including Disney, Calvin Klein, Gap, Inc., Revlon, PepsiCo, Liz Claiborne, and Playboy, bringing a wealth of brand-building and transformational expertise to Niagen Bioscience's strategic initiatives.
How do I contact Kristin Patrick?
Has Kristin Patrick been buying or selling shares of Niagen Bioscience?
Kristin Patrick has not been actively trading shares of Niagen Bioscience in the last ninety days. Most recently, Kristin Patrick sold 23,000 shares of the business's stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $3.57, for a transaction totalling $82,110.00. Learn More on Kristin Patrick's trading history.
Who are Niagen Bioscience's active insiders?
Are insiders buying or selling shares of Niagen Bioscience?
In the last twelve months, Niagen Bioscience insiders bought shares 2 times. They purchased a total of 6,685 shares worth more than $45,613.65. In the last twelve months, insiders at the sold shares 1 times. They sold a total of 37,161 shares worth more than $230,026.59. The most recent insider tranaction occured on November, 14th when CFO Ozan Pamir bought 4,465 shares worth more than $30,406.65. Insiders at Niagen Bioscience own 9.4% of the company.
Learn More about insider trades at Niagen Bioscience. Information on this page was last updated on 11/14/2025.
